Real-world-data Enabled Assessment for heaLth regulatory decision-Making

Informazioni relative al progetto

REALM

ID dell’accordo di sovvenzione: 101095435

DOI

10.3030/101095435

Data della firma CE 24 Novembre 2022

Data di avvio 1 Gennaio 2023

Data di completamento 31 Dicembre 2026

Finanziato da

• Health

Costo totale

€ 6 659 650,00

Contributo UE

€ 6 659 650,00

Coordinato da

UNIVERSITEIT MAASTRICHT
Netherlands

Periodic Reporting for period 1 - REALM (Real-world-data Enabled Assessment for heaLth regulatory decision-Making)

Periodo di rendicontazione: 2023-01-01 al 2024-06-30

Sintesi del contesto e degli obiettivi generali del progetto

The REALM project addresses the growing need for a standardized, transparent, and collaborative framework for evaluating and certifying healthcare software. As medical software increasingly plays a critical role in healthcare delivery, the lack of consistent regulatory guidelines and evaluation processes poses significant challenges. REALM aims to bridge this gap by creating a regulatory sandbox environment where developers, regulatory authorities, healthcare professionals, and policy officers can collaborate. This platform will standardize tools and data resources, ensuring that healthcare software meets high-quality standards across the European Union and beyond.

The project's impact is expected to be substantial, fostering trust in digital health technologies and enabling faster, more efficient certification processes. By integrating real-world data, synthetic data, and a living lab environment, REALM will enhance the reliability and safety of medical software. The inclusion of social sciences and humanities in the project ensures that ethical considerations and human-centered approaches are integral to the software development and evaluation process, further aligning the project with EU policy priorities.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

During the first phase of the REALM project, significant progress was made in developing the technical and scientific foundations necessary for a standardized evaluation and certification framework for healthcare software. Key activities included the comprehensive mapping and analysis of existing healthcare software regulations, which informed the design of the project’s core architecture.
The team successfully initiated the development of five critical components: Model Cards for standardized software documentation, a Federated Cloud-Based Data Resources Catalog, a Regulatory Toolbox, a Living Lab Environment, and a Post-Marketing Surveillance Module. These components collectively lay the groundwork for a robust platform that will enhance the reliability, transparency, and efficiency of healthcare software certification. Early testing and integration of these tools have already begun, marking significant technical milestones in the project.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The REALM project has achieved significant advancements beyond the current state of the art in healthcare software evaluation. Key innovations include the development of Model Cards, which provide a standardized template for documenting software details, performance, and limitations. This innovation is crucial for ensuring transparency and consistency across the REALM platform.

Technically, the project has implemented Apache Kafka to facilitate seamless communication between the RIANA dashboard and the REALM backbone, marking a critical step in creating an integrated infrastructure. Ongoing analyses for integrating Blockchain technology are also underway, aiming to enhance data security and traceability within the platform.

These advancements position REALM as a frontrunner in setting new standards for healthcare software certification. However, to ensure widespread adoption and success, further research, market access strategies, commercialization efforts, and the development of supportive regulatory and standardization frameworks will be essential.